Gla-300 Comparable to IDeg-100 for Uncontrolled Type 2 Diabetes Gla-300 Comparable to IDeg-100 for Uncontrolled Type 2 Diabetes

A head-to-head study of glargine 300 units/mL (Gla-300) and degludec 100 units/mL (IDeg-100) showed that both of these second-generation basal insulin analogs were comparable for treating uncontrolled type 2 diabetes, although hypoglycemia rates were lower with Gla-300 during the titration period, researchers say.Reuters Health Information
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news